Status:
COMPLETED
Closing the Loop in Adults With Type 1 Diabetes
Lead Sponsor:
University of Cambridge
Collaborating Sponsors:
Cambridge University Hospitals NHS Foundation Trust
Diabetes UK
Conditions:
Type 1 Diabetes
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The main objective of this study is to evaluate the feasibility of closed loop insulin pump therapy to improve overnight glucose control in adults with type 1 diabetes.
Detailed Description
People with type 1 diabetes(T1D) need regular insulin injections or continuous delivery of insulin using an insulin pump in order to keep the blood glucose levels normal. We know that keeping blood su...
Eligibility Criteria
Inclusion
- Type 1 diabetes, as defined by WHO for at least 6 months or confirmed C-peptide negative.
- On insulin pump therapy for at least 3 months
Exclusion
- Non-type 1 diabetes mellitus
- Any physical/psychological disease likely to interfere with the study
- Taking medication likely to interfere with interpretation of the results
- Known/suspected allergy against insulin
- Patients with clinically significant nephropathy, neuropathy or retinopathy as judged by the investigator
- Ongoing severe recurrent hypoglycaemia as judged by the investigator.
Key Trial Info
Start Date :
February 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2009
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT00910767
Start Date
February 1 2009
End Date
July 1 2009
Last Update
September 17 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Addenbrooke's Hospital
Cambridge, United Kingdom, CB2 0QQ